PubRank

E Jaffee

Author PubWeight™ 33.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 1993 11.95
2 Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994 6.73
3 Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001 4.19
4 Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000 3.78
5 A white paper: the product of a pancreas cancer think tank. Cancer Res 2001 1.39
6 Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations. Cytogenet Genome Res 2007 1.02
7 Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma. J Viral Hepat 2012 0.92
8 An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin. J Immunol 2001 0.83
9 Use and benefits of a Web site for pancreatic cancer. JAMA 1998 0.77
10 Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene. Ann Surg 1997 0.77
11 Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses. Ciba Found Symp 1994 0.76
12 T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma. Cytotherapy 2002 0.75